Technology

Immuron (Warrant)

$1.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (+8.55%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can watch IMRNW and buy or sell other stocks, options, and ETFs commission-free!

About IMRNW

Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States. The HyperImmune Products segment comprises of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia. The listed name for IMRNW is Immuron Limited Warrants.

CEO
Jerry Kanellos, PhD
Employees
—
Headquarters
Carlton, Victoria (VIC)
Founded
1994
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
11.63K
High Today
$1.29
Low Today
$1.17
Open Price
$1.17
Volume
15.08K
52 Week High
$11.19
52 Week Low
$0.2113

Collections

You May Also Like

BKAG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure